The founders of Dimension have strong investment track records but listening to Brad Loncar’s interview with Zavain Dar does the best job I’ve heard to date as to the advantage of having deep expertise in both data/analytics and biology come together at the beginning rather than have biotech be an add-on to a tech fund. Exciting times to watch what these investors will be up to. Congratulations Zaven Kaprielian , Adam Goulburn, and Nan Li .
𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: Dimension's Zavain Dar talks about raising a $500M second fund, and describes the firm's ethos of investing in companies that are highly focused in both life sciences and technology. He discusses the founding of Dimension, and highlights entrepreneurs and portfolio companies that have matched the firm's focused investment objective. Full video: https://lnkd.in/g7sQ9Nvt BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | NYSE | Allucent | Klein Hersh
